Case number 2:19-cv-14737
ASTRAZENECA LP et al v. HEC PHARM CO., LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 13, 2020 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated. (ld, ) |
| Jan 13, 2020 | 13 | Order (3) Docket Text: ORDER/CONSENT JUDGMENT; This District Court has jurisdiction over the subject matter of the above action and has personal jurisdiction over the parties. Unless otherwise specifically authorized pursuant to the SettlementAgreement, Defendant, including any of its Affiliates, successors and assigns, is enjoined from infringing the Licensed Patents, on its own part or through any Affiliate, by making, having made, using, selling, offering to sell, importing, or distributing of the Defendant Product. Compliance with this Consent Judgment may be enforced by AstraZeneca and its successors in interest, or assigns, as permitted by the terms of the Settlement Agreement; All claims, counterclaims, affirmative defenses, and demands in this action are hereby dismissed with prejudice and without costs, disbursements or attorneys' fees to any party.. Signed by Judge Claire C. Cecchi on 1/13/2020. (ld, ) |
| Dec 11, 2019 | 12 | Letter (1) |
| Dec 11, 2019 | 12 | Text of Proposed Order (3) |
| Dec 11, 2019 | 12 | Main Document (1) Docket Text: Letter from Plaintiffs to Hon. Claire C. Cecchi, USDJ. (Attachments: # (1) Text of Proposed Order)(BETZ, CYNTHIA) |
| Sep 9, 2019 | 11 | Order (1) Docket Text: STIPULATION AND ORDER that Defendants' time to answer, move or otherwise reply to Plaintiffs' Complaint is hereby extended through and including November 8, 2019.. Signed by Chief Mag. Judge Mark Falk on 9/9/2019. (ld, ) |
| Sep 5, 2019 | 10 | Letter (1) |
| Sep 5, 2019 | 10 | Text of Proposed Order (2) |
| Sep 5, 2019 | 10 | Main Document (1) Docket Text: Letter from Plaintiffs to Hon. Mark Falk, USMJ re [8] Stipulation and Order. (Attachments: # (1) Text of Proposed Order)(FLAHERTY, JOHN) |
| Aug 29, 2019 | 9 | Notice to Withdraw from NEF as to Case (2) Docket Text: Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney RAVIN R. PATEL terminated. (PATEL, RAVIN) |
| Jul 15, 2019 | 8 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER that Defendants' time to answer, move or otherwise reply to Plaintiffs' Complaint is hereby extended through and including September 9, 2019.. Signed by Magistrate Judge Mark Falk on 7/15/2019. (ld, ) |
| Jul 12, 2019 | 7 | Letter (1) |
| Jul 12, 2019 | 7 | Text of Proposed Order (2) |
| Jul 12, 2019 | 7 | Main Document (1) Docket Text: Letter from John E. Flaherty to the Hon. Mark Falk, U.S.M.J. (Attachments: # (1) Text of Proposed Order)(FLAHERTY, JOHN) |
| Jul 9, 2019 | N/A | Patent Pilot Reassignment (0) Docket Text: Text Minute Entry for proceedings held before Judge Michael A. Shipp: Pursuant to Local Patent Rule 1.5 Patent Pilot Project, case shall be reassigned to a designated patent judge. (gxh) |
| Jul 9, 2019 | 6 | Order Reassigning Case (2) Docket Text: ORDER REALLOCATING AND REASSIGNING CASE. Case Number 3:19-cv-14737. Case reallocated to Newark and reassigned to Judge Claire C. Cecchi and Magistrate Judge Mark Falk for all further proceedings. Judge Michael A. Shipp, Magistrate Judge Tonianne J. Bongiovanni no longer assigned to case. Signed by Chief Judge Freda L. Wolfson on 7/9/2019. (jjc) |
| Jul 8, 2019 | N/A | Add and Terminate Judges (0) Docket Text: Judge Michael A. Shipp and Magistrate Judge Tonianne J. Bongiovanni added. (jdb) |
| Jul 8, 2019 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jdb) |
| Jul 8, 2019 | 5 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to HEC PHARM CO., LTD., HEC PHARM USA. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jdb) |
| Jul 3, 2019 | 1 | Complaint (19) |
| Jul 3, 2019 | 1 | Exhibit A (15) |
| Jul 3, 2019 | 1 | Exhibit B (20) |
| Jul 3, 2019 | 1 | Exhibit C (17) |
| Jul 3, 2019 | 1 | Civil Cover Sheet (1) |
| Jul 3, 2019 | 2 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by ASTRAZENECA AB, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (FLAHERTY, JOHN) |
| Jul 3, 2019 | 3 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by RAVIN R. PATEL on behalf of ASTRAZENECA AB, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED (PATEL, RAVIN) |
| Jul 3, 2019 | 1 | Main Document (19) Docket Text: COMPLAINT against HEC PHARM CO., LTD., HEC PHARM USA ( Filing and Admin fee $ 400 receipt number 0312-9792284), filed by ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Civil Cover Sheet)(FLAHERTY, JOHN) |
| Jul 3, 2019 | 1 | Complaint* (1) |
